Briacell Therapeutics Corp (BCTX) — Strategic Asset Allocation Index
Briacell Therapeutics Corp (BCTX) has a Strategic Asset Allocation Index of 3.2% as of April 2026. Strategic assets (PP&E of $- plus long-term investments of $750.98K) total $750.98K, measured against net assets of $23.41 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check BCTX financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Briacell Therapeutics Corp Strategic Asset Allocation Index (2017–2022)
This chart shows how Briacell Therapeutics Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2017 to 2022. As of April 2026, the index stands at 3.2%, representing strategic assets of $750.98K against net assets of $23.41 Million USD. See how financially flexible is Briacell Therapeutics Corp to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Briacell Therapeutics Corp (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Briacell Therapeutics Corp from 2017 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see BCTX market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $2.00 | $- | $2.00 | $13.25 Million | ▲ +0.0 pp |
| 2021 | 0.0% | $2.00 | $- | $2.00 | $34.58 Million | ▼ 0.0 pp |
| 2018 | 0.0% | $2.00 | $- | $2.00 | $945.02K | ▼ 0.0 pp |
| 2017 | 0.0% | $2.00 | $- | $2.00 | $750.23K | — |